What's new

Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised

Feb 11, 2025 - 15:30
 0
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

BJ’s Wholesale Club to open distribution center in Ohio

Next Article

Hugo Boss renews childrenswear license with CWF until 2029

Related Posts

Notifying a change of marketing status

Notifying a change of marketing status

Mar 25, 2025  0

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 10, 2025  0

Mandate, objectives and composition of the Healthcare P...

Apr 2, 2025  0